Cas:374-88-9 Undecafluorocyclohexanecarboxylic acid manufacturer & supplier

Chemical Name:Undecafluorocyclohexanecarboxylic acid

CAS.NO:374-88-9

Synonyms:1,2,2,3,3,4,4,5,5,6,6-undecafluorocyclohexane-1-carboxylic acid;Undecafluorocyclohexanecarboxylic acid;Cyclohexanecarboxylic acid, 1,2,2,3,3,4,4,5,5,6,6-undecafluoro-

Molecular Formula:C₇HF₁₁O₂

Molecular Weight:326.064

HS Code:

Physical and Chemical Properties:

Melting point:N/A

Boiling point:176.2±40.0 °C at 760 mmHg

Density:1.8±0.1 g/cm3

Index of Refraction:1.318

PSA:37.30000

Exact Mass:325.980103

LogP:3.76

Material Safety Information (Applicable for Hazard Chemicals)

RIDADR:UN 3265

Packing Group:

Contact us for information like 1,2,2,3,3,4,4,5,5,6,6-undecafluorocyclohexane-1-carboxylic acid chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,Cyclohexanecarboxylic acid, 1,2,2,3,3,4,4,5,5,6,6-undecafluoro- physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,1,2,2,3,3,4,4,5,5,6,6-undecafluorocyclohexane-1-carboxylic acid Use and application,Cyclohexanecarboxylic acid, 1,2,2,3,3,4,4,5,5,6,6-undecafluoro- technical grade,usp/ep/jp grade.

Related News: Last month, Emergent Chief Executive Robert Kramer said it was his understanding that there are 100 million doses of J&J’s vaccine ready for FDA review and that regulators had begun the review process. Undecafluorocyclohexanecarboxylic acid manufacturer Green Valley said it would launch the drug ��very soon�� in China. The company also aims to roll out a phase-3 clinical trial with sites in the United States, Europe and Asia in early 2020 to facilitate global regulatory approval of the drug. Undecafluorocyclohexanecarboxylic acid supplier South Korea said on Sunday that it would deny entry to any foreigners who have traveled to Wuhan and surrounding Hubei Province in China in the past 14 days. Undecafluorocyclohexanecarboxylic acid vendor Green Valley said it would launch the drug ��very soon�� in China. The company also aims to roll out a phase-3 clinical trial with sites in the United States, Europe and Asia in early 2020 to facilitate global regulatory approval of the drug. Undecafluorocyclohexanecarboxylic acid factory Last month, Emergent Chief Executive Robert Kramer said it was his understanding that there are 100 million doses of J&J’s vaccine ready for FDA review and that regulators had begun the review process.